Discovery of protease inhibitors using targeted libraries

Current Opinion in Chemical Biology

Volumn 2, Issue 3, 1998, Pages 386-396

  Whittaker, Mark ^a  

^a British Biotech Pharmaceuticals Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; OLIGOPEPTIDE; PROTEINASE INHIBITOR;

CHEMICAL STRUCTURE; CHEMISTRY; DRUG DESIGN; METHODOLOGY; ORGANIC CHEMISTRY; PATENT; REVIEW; SYNTHESIS;

CHEMISTRY, ORGANIC; DRUG DESIGN; INDICATORS AND REAGENTS; MOLECULAR STRUCTURE; OLIGOPEPTIDES; PATENTS; PROTEASE INHIBITORS;

EID: 0032087776     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(98)80014-8     Document Type: Article

References (45)

1. Babine RE, Bender SL: Molecular recognition of protein-ligand complexes: applications to drug design. Chem Rev 1997, 97:1359-1472. A thorough review on structure-based design that encompasses aspartyl, serine, cysleine and matrix metalloproteinase enzyme inhibitors.
2. Kick EK, Roe DC, Skillman AG, Liu G, Ewing TJA, Sun Y, Kuntz ID, Ellman JA: Structure-based design and combinatorial chemistry yield low nanomolar inhibitors of cathepsin D. Chem Biol 1997, 97:297-307. This account of the identification of potent inhibitors of the aspartyl protease cathepsin D illustrates the merit of utilising a structure-based design approach for the selection of substituents within a targeted combinatorial library.
3. Dolle RE: Discovery of enzyme inhibitors through combinatorial chemistry. Mol Divers 1996, 2:223-236. This key review summarises the literature (up to and including most of 1996) on the use of combinatorial libraries in the identification of both protease inhibitors and compounds active against nonproteolytic enzymes.
4. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia-Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP et al.: A combinatorial approach defines specificities of members of the caspase family and granzyme B. J Biol Chem 1997, 272:17907-17911.
5. Rano TA, Timkey T, Peterson EP, Rotonda J, Nicholson DW, Becker JW, Chapman KT, Thornberry NA: A combinatorial approach for determining protease specificities: application to interleukin-1β converting enzyme (ICE). Chem Biol 1997, 4:149-155.
6. Thaisrivongs S: HIV protease inhibitors. Annu Rep Med Chem 1994, 29:133-144.
7. Kick EK, Ellman JA: Expedient method for the solid-phase synthesis of aspartic acid protease inhibitors directed toward the generation of libraries. J Med Chem 1995, 38:1427-1430.
8. 2 symmetric inhibitors of HIV protease containing diamino diol and diamino alcohol cores. J Med Chem 1995, 38:2995-3002.
9. Ellman J, Stoddard B, Wells J: Combinatorial thinking in chemistry and biology. Proc Natl Acad Sci USA 1997, 94:2779-2782.
10. Thompson LA, Ellman JA: Straightforward and general method for coupling alcohols to solid supports. Tetrahedron Lett 1994, 35:9333-9336.
11. Wallace OB: Solid phase synthesis of ketones from esters. Tetrahedron Lett 1997, 38:4939-4942.
12. Mukhopadhyay M, Bhatia B, Iqbal J: Cobalt catalyzed multiple component condensation route to β-acetamido carbonyl compound libraries. Tetrahedron Lett 1997, 38:1083-1086.
13. Hlasta DJ, Pagani ED: Human leukocyte elastase inhibitors. Annu Rep Med Chem 1994, 29:195-204.
14. Ripka WC, Vlasuk GP: Antithrombotics/serine proteases. Annu Rep Med Chem 1997, 32:71-89.
15. Otto H-H, Schirmeister T: Cysteine proteases and their inhibitors. Chem Rev 1997, 97:133-171.
16. Baldino CM, Casebier DS, Caserta JC, Slobodkin G, Tu C, Coffen DL: Convergent parallel synthesis. Synlett 1997:488-490. A publication from the Arqule group illustrating that parallel solution phase methods can provide a practical alternative to solid-phase methods for targeted library synthesis.
17. Pitlik J, Townsend CA: Solution phase synthesis of a combinatorial monocyclic β-lactam library: potential protease inhibitors. Bioorg Med Chem Lett 1997, 7:3129-3134.
18. Fehrentz JA, Paris M, Heitz A, Velek J, Winternitz F, Martinez J: Solid phase synthesis of C-terminal peptide aldehydes. J Org Chem 1997, 62:6792-6796.
19. Zask A, Levin JI, Killar LM, Skolnicki JS: Inhibition of matrix metalloproteinases: structure based design. Curr Pharm Design 1996, 2:624-661.
20. Davidson AH, Drummond AH, Galloway WA, Whittaker M: The inhibition of matrix metalloproteinase enzymes. Chem Ind 1997:258-261.
21. Murphy MM, Schullek JR, Gordon EM, Gallop MA: Combinatorial organic synthesis of highly functionalized pyrrolidines: identification of a potent angiotensin converting enzyme inhibitor from a mercaptoacyl proline library. J Am Chem Soc 1995, 117:7029-7030.
22. Ni Z-J, Maclean D, Holmes CP, Murphy MM, Ruhland B, Jacobs JW, Gordon EM, Gallop MA: Versatile approach to encoding combinatorial organic syntheses using chemically robust secondary amine tags. J Med Chem 1996, 39:1601-1608. The first report of the Affymax single bead encoding methodology that involves the use of an N-[(dialkylcarbamoyl)methyl] glycine coding oligomer. Decoding involves acidolytic secondary amine formation, dansylation and analysis by reverse phase high performance liquid chromatography.
23. Maclean D, Schullek JR, Murphy MM, Ni Z-J, Gordon EM, Gallop MA: Encoded combinatorial chemistry: synthesis and screening of a library of highly functionalized pyrrolidines. Proc Natl Acad Sci USA 1997, 94:2805-2810. This is an important paper because it demonstrates the utility of the Affymax secondary amine tag encoding methodology in the identification of an active inhibitor from a library targeted for angiotensin-converting enzyme inhibition. The advantage of this technique over iterative deconvolution is that structure-activity relationship data can be obtained from single bead assays.
24. Blackburn C, Pingali A. Kehoe T, Herman LW, Wang H, Kates SA: Libraries of angiotensin converting enzyme inhibitors: solid-phase synthesis and affinity selection. Bioorg Med Chem Lett 1997, 7:823-826. The use of affinity selection in conjunction with mass spectroscopy as described in this preliminary account provides a method for screening large mixtures of compounds prepared by combinatorial methods.
25. ••], who used structural information to direct the library design.
26. Esser CK, Kevin NJ, Yates NA, Chapman KT: Solid phase synthesis of a N-carboxylalkyl tripeptide combinatorial library. Bioorg Med Chem Lett 1997, 7:2639-2644. This paper illustrates that a combined split/pool and indexed library strategy can lead to useful structure-activity relationship data from the initial screen of a targeted library.
27. Kevin NJ, Esser CK, Chapman KT, Hagmann WK, Yates NA, Kostura MJ, Pacholok SG, Si Q: The synthesis of a 4-dimensional N-carboxymethyl peptide combinatorial library for new lead generation against metalloproteinases utilizing both mix and split and indexed library strategies. Abstract MEDI 113 of the 213th ACS National Meeting: 1997 13-17 April; San Francisco, Washington DC: American Chemical Society; 1997.
28. Foley MA, Hassman AS, Drewry DH, Greer DG, Wagner CD, Feldman PL, Berman J, Bickett DM, McGeehan GM, Lambert MH, Green M: Rapid synthesis of novel dipeptide inhibitors of human collagenase and gelatinase using solid phase chemistry. Bioorg Med Chem Lett 1996, 6:1905-1910. This report describes the parallel synthesis of potent inhibitors of MMP-1 and MMP-9 that feature a thiol ZBG.
29. Campbell DA, Bermak JC: Solid-phase synthesis of peptidylphosphonates. J Am Chem Soc 1994, 116:6039-6040.
30. Campbell DA, Bermak JC, Burkoth TS, Patel DV: A transition state analogue inhibitor combinatorial library. J Am Chem Soc 1995, 117:5381-5382.
31. Schullek JR, Butler JH, Ni Z-J, Chen D, Yuan Z: A high-density screening format for encoded combinatorial libraries: assay miniaturisation and its application to enzymatic reactions. Anal Biochem 1997, 246:20-29. This paper describes the preparation of a library of MMP-7 inhibitors that were screened in a novel miniaturised format and identified by tag encoding.
32. Whittaker M, Floyd CN, Leblanc CJ, Lewis CN, Miller A, Saroglou L, Patel S: Parallel synthesis of matrix metalloproteinase inhibitors. Abstract 76 of the 7th International Kyoto Conference on New Aspects of Organic Chemistry: 1997 10-14 November: Kyoto, Kyoto: IKCOC; 1997.
33. Bauer U, Ho W-B, Koskinen AMP: A novel linkage for the solid-phase synthesis of hydroxamic acids. Tetrahedron Lett 1997, 38:7233-7236.
34. Floyd CD, Lewis CN, Patel SR, Whittaker M: A method for the synthesis of hydroxamic acids on solid phase. Tetrahedron Lett 1996, 37:8045-8048.
35. Richter LS, Desai MC: A TFA-cleavable linkage for solid-phase synthesis of hydroxamic acids. Tetrahedron Lett 1997, 38:321-322.
36. Gordeev MF, Hui HC, Gordon EM, Patel DV: A general and efficient solid phase synthesis of quinazoline-2.4-diones. Tetrahedron Lett 1997, 38:1729-1732.
37. Mellor SL, McGuire C, Chan WC: N-Fmoc-aminooxy-2-chlorotrityl polystyrene resin: a facile solid-phase methodology for the synthesis of hydroxamic acids. Tetrahedron Lett 1997, 38:3311-3314.
38. Mellor SL, Chan WC: 4-[2,4-dimethoxyphenyl(N-fluoren-9-ylmethoxycabonyl-N-alkylaminooxy)-methyl] pheroxymethyl polystyrene: a multiple solid phase approach to N-alkylhydroxamic acids. J Chem Soc Chem Commun 1997:2005-2006.
39. Ngu K, Patel DV: A new and efficient solid phase synthesis of hydroxamic acids. J Org Chem 1997, 62:7088-7089.
40. Dankwardt SM, Smith DB, Porco JA, Nguyen CH: Solid phase synthesis of N-alkyl sulfonamides. Synlett 1997:854-856.
41. Chen JJ, Spatola AF: Solid phase synthesis of peptide hydroxamic acids. Tetrahedron Lett 1997, 38:1511-1514.
42. Ferry G, Boutin JA, Atassi G, Fauchere J-L, Tucker GC: Selection of a histidine-containing inhibitor of gelatinases through deconvolution of combinatorial tetrapeptide libraries. Mol Divers 1996, 2:135-146.
43. Salemme FR Spurlino J, Bone R: Serendipity meets precision: the integration of structure-based drug design and combinatorial chemistry for efficient drug discovery. Structure 1997, 5:319-324.
44. Bastos M, Maeji NJ, Abeles RH: Inhibitors of human heart chymase based on a peptide library. Prod Natl Acad Sci USA 1995, 92:6738-6742.
45. Burger MT, Bartlett PA; Enzymatic, polymer-supported formation of an analog of the trypsin inhibitor A90720A: a screening strategy for macrocyclic peptidase inhibitors. J Am Chem Soc 1997, 119: 12697-12698. In this study, trypsin is used to catalyse the reverse (amide synthesis) reaction for a polymer-supported peptidic amino ester. Structures that cyclised were distinguished from those that did not cyclise by the inclusion of a base labile ester bond within the sequence. Treatment with base resulted in the loss of a dye-labelled fragment from noncyclised structures but beads for which the cyclisation occured remained coloured, The structures of the cyclised sequences could be used as the basis for inhibitor design.